Neuroleptic treatment of oligophrenic patients| A DOUBLE‐BLIND CLINICAL MULTICENTRE TRIAL OF CIS(Z)‐CLOPENTHIXOL AND HALOPERIDOL

Acta Psychiatrica Scandinavica

Volumn 64, Issue , 1981, Pages 039-045

  Karsten, D ^a   Kivimaki T ^a   Linna, S L ^a   Pollari, L ^a   Turunen, S ^a  

^a Paimio Central Institution ^*  (Finland)

Author keywords

cis(Z) clopenthixol; double blind trial; haloperidol.; Mental retardation

Indexed keywords

CLOPENTHIXOL; HALOPERIDOL; THIOXANTHENE DERIVATIVE;

ADULT; ARTICLE; BEHAVIOR; CLINICAL TRIAL; COMPARATIVE STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MALE; MENTAL DEFICIENCY; RATING SCALE; STEREOISOMERISM; ADVERSE DRUG REACTION; ANXIETY; BLADDER; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DROWSINESS; DRUG COMPARISON; EXTRAPYRAMIDAL SYMPTOM; MAJOR CLINICAL STUDY; MICTURITION; MOUTH; OLIGOPHRENIA; ORAL DRUG ADMINISTRATION; SWEATING; TARDIVE DYSKINESIA; THERAPY; VERTIGO; XEROSTOMIA;

ADULT; BEHAVIOR; CLINICAL TRIALS; CLOPENTHIXOL; COMPARATIVE STUDY; DOUBLE-BLIND METHOD; FEMALE; HALOPERIDOL; HUMAN; MALE; MENTAL RETARDATION; MIDDLE AGE; PSYCHIATRIC STATUS RATING SCALES; STEREOISOMERISM; THIOXANTHENES;

EID: 84995202149     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1981.tb06212.x     Document Type: Article

References (3)

1. Overview of psychopharmacology for the retarded in the United States